JP Patent

JP5042863B2 — 生物学的に活性な分子をデリバリーするための脂質ナノ粒子系組成物および方法

Assigned to Sirna Therapeutics Inc · Expires 2012-10-03 · 14y expired

What this patent protects

Patent listed against inclisiran-sodium.

Drugs covered by this patent

inclisiran-sodium (INCLISIRAN SODIUM)

Patent Metadata

Patent number: JP5042863B2
Jurisdiction: JP
Classification: —
Expires: 2012-10-03
Drug substance claim: No
Drug product claim: No
Assignee: Sirna Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.